|
1
|
Yoo JY, Wang XW, Rishi AK, Lessor T, Xia
XM, Gustafson TA and Hamburger AW: Interaction of the PA2G4 (EBP1)
protein with ErbB-3 and regulation of this binding by heregulin. Br
J Cancer. 82:683–690. 2000.PubMed/NCBI
|
|
2
|
Lessor TJ, Yoo JY, Xia X, Woodford N and
Hamburger AW: Ectopic expression of the ErbB-3 binding protein Ebp1
inhibits growth and induces differentiation of human breast cancer
cell lines. J Cell Physiol. 183:321–329. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yamada H, Mori H, Momoi H, Nakagawa Y,
Ueguchi C and Mizuno T: A fission yeast gene encoding a protein
that preferentially associates with curved DNA. Yeast. 10:883–894.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang Y and Hamburger AW: Heregulin
regulates the ability of the ErbB3-binding protein Ebp1 to bind E2F
promoter elements and repress E2F-mediated transcription. J Biol
Chem. 279:26126–26133. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Monie TP, Perrin AJ, Birtley JR, Sweeney
TR, Karakasiliotis I, Chaudhry Y, Roberts LO, Matthews S,
Goodfellow IG and Curry S: Structural insights into the
transcriptional and translational roles of Ebp1. EMBO J.
26:3936–3944. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ahn JY, Liu X, Liu Z, Pereira L, Cheng D,
Peng J, Wade PA, Hamburger AW and Ye K: Nuclear Akt associates with
PKC-phosphorylated Ebp1, preventing DNA fragmentation by inhibition
of caspase-activated DNase. EMBO J. 25:2083–2095. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Radomski N and Jost E: Molecular cloning
of a murine cDNA encoding a novel protein, p38-2G4, which varies
with the cell cycle. Exp Cell Res. 220:434–445. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang YX, Woodford N, Xia XM and Hamburger
AW: Repression of E2F1-mediated transcription by the ErbB3 binding
protein Ebp1 involves histone deacetylases. Nucleic Acid Res.
31:2168–2177. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang YX, Fondell JD, Wang QB, Xia XM,
Cheng AW, Lu ML and Hamburger AW: Repression of androgen receptor
mediated transcription by the ErbB-3 binding protein, Ebp1.
Oncogene. 21:5609–5618. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Wang XW, Jelovac D, Nakanishi T,
Yu MH, Akinmade D, Goloubeva O, Ross DD, Brodie A and Hamburger AW:
The ErbB3-binding protein Ebp1 suppresses androgen
receptor-mediated gene transcription and tumorigenesis of prostate
cancer cells. Proc Natl Acad Sci USA. 102:9890–9895. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Akinmade D and Hamburger AW: The
ErbB3 binding protein Ebp1 interacts with Sin3A to repress E2F1 and
AR-mediated transcription. Nucleic Acid Res. 33:6024–6033. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Squatrito M, Mancino M, Donzelli M, Areces
LB and Draetta GF: EBP1 is a nucleolar growth-regulating protein
that is part of pre-ribosomal ribonucleoprotein complexes.
Oncogene. 23:4454–4465. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Squatrito M, Mancino M, Sala L and Draetta
GF: Ebp1 is a dsRNA-binding protein associated with ribosomes that
modulates eIF2alpha phosphorylation. Biochem Biophys Res Commun.
344:859–868. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou H, Mazan-Mamczarz K, Martindale JL,
Barker A, Liu Z, Gorospe M, Leedman PJ, Gartenhaus RB, Hamburger AW
and Zhang Y: Post-transcriptional regulation of androgen receptor
mRNA by an ErbB3 binding protein 1 in prostate cancer. Nucleic
Acids Res. 38:3619–3631. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bose SK, Sengupta TK, Bandyopadhyay S and
Spicer EK: Identification of Ebp1 as a component of cytoplasmic
bcl-2 mRNP (messenger ribonucleoprotein particle) complexes.
Biochem J. 396:99–107. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Corso C, Pisapia L, Citro A, Cicatiello V,
Barba P, Cigliano L, Abrescia P, Maffei A, Manco G and Del Pozzo G:
EBP1 and DRBP76/NF90 binding proteins are included in the major
histocompatibility complex class II RNA operon. Nucleic Acids Res.
39:7263–7275. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Akinmade D, Lee M, Zhang Y and Hamburger
AW: Ebp1-mediated inhibition of cell growth requires serine 363
phosphorylation. Int J Oncol. 31:851–858. 2007.PubMed/NCBI
|
|
18
|
Akinmade D, Talukder AH, Zhang Y, Luo WM,
Kumar R and Hamburger AW: Phosphorylation of the ErbB3 binding
protein Ebp1 by p21-activated kinase 1 in breast cancer cells. Br J
Cancer. 98:1132–1140. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y and Hamburger AW: Specificity and
heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated
repression of androgen receptor signalling. Br J Cancer.
92:140–146. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Y, Akinmade D and Hamburger AW:
Inhibition of heregulin mediated MCF-7 breast cancer cell growth by
the ErbB3 binding protein EBP1. Cancer Lett. 265:298–306. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu Y, Zhou H, Chen W, Zhang Y and
Hamburger AW: The ErbB3 binding protein EBP1 regulates ErbB2
protein levels and tamoxifen sensitivity in breast cancer cells.
Breast Cancer Res Treat. 126:27–36. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Scott GK, Marx C, Berger CE, Saunders LR,
Verdin E, Schafer S, Jung M and Benz CC: Destabilization of ERBB2
transcripts by targeting 3′ untranslated region messenger RNA
associated HuR and histone deacetylase-6. Mol Cancer Res.
6:1250–1258. 2008.PubMed/NCBI
|
|
23
|
Delacroix L, Begon D, Chatel G, Jackers P
and Winkler R: Distal ERBB2 promoter fragment displays specific
transcriptional and nuclear binding activities in ERBB2
overexpressing breast cancer cells. DNA Cell Biol. 24:582–594.
2005. View Article : Google Scholar
|
|
24
|
Hua G, Zhu B, Rosa F, Deblon N, Adelaide
J, Kahn-Perles B, Birnbaum D and Imbert J: A negative feedback
regulatory loop associates the tyrosine kinase receptor ERBB2 and
the transcription factor GATA4 in breast cancer cells. Mol Cancer
Res. 7:402–414. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shang Y, Myers M and Brown M: Formation of
the androgen receptor transcription complex. Mol Cell. 9:601–610.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hynes NE and Lane HA: ERBB receptors and
cancer: the complexity of targeted inhibitors. Nat Rev Cancer.
5:341–354. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Benz CC, O’Hagan RC, Richter B, Scott GK,
Chang CH, Xiong X, Chew K, Ljung BM, Edgerton S, Thor A and Hassell
JA: HER2/Neu and the Ets transcription activator PEA3 are
coordinately upregulated in human breast cancer. Oncogene.
15:1513–1525. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hurst HC: Update on HER-2 as a target for
cancer therapy: the ERBB2 promoter and its exploitation for cancer
treatment. Breast Cancer Res. 3:395–398. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qin HR, Iliopoulos D, Nakamura T,
Costinean S, Volinia S, Druck T, Sun J, Okumura H and Huebner K:
Wwox suppresses prostate cancer cell growth through modulation of
ErbB2-mediated androgen receptor signaling. Mol Cancer Res.
5:957–965. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lewis GD, Lofgren JA, McMurtrey AE,
Nuijens A, Fendly BM, Bauer KD and Sliwkowski MX: Growth regulation
of human breast and ovarian tumor cells by heregulin: Evidence for
the requirement of ErbB2 as a critical component in mediating
heregulin responsiveness. Cancer Res. 56:1457–1465. 1996.
|
|
31
|
Diermeier-Daucher S, Breindl S, Buchholz
S, Ortmann O and Brockhoff G: Modular anti-EGFR and anti-Her2
targeting of SK-BR-3 and BT474 breast cancer cell lines in the
presence of ErbB receptor-specific growth factors. Cytometry A.
79:684–693. 2011.PubMed/NCBI
|
